載入...
Nordamnacanthal potentiates the cytotoxic effects of tamoxifen in human breast cancer cells
Tamoxifen (TAM) is the mainline drug treatment for breast cancer, despite its side effects and the development of resistance. As an alternative approach, in the present study a novel combination therapy was established through combining TAM with nordamnacanthal (NDAM) in order to investigate the add...
Na minha lista:
| 發表在: | Oncol Lett |
|---|---|
| Main Authors: | , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
D.A. Spandidos
2015
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4247001/ https://ncbi.nlm.nih.gov/pubmed/25435988 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2014.2697 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|